(Q28575693)

31 January 2017

title

ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis (English)

1 reference

31 January 2017

0 references

1 reference

Navjotsingh Pabla

1

1 reference

31 January 2017

Shuang Huang

2

1 reference

31 January 2017

Qing-Sheng Mi

3

1 reference

31 January 2017

Rene Daniel

4

1 reference

31 January 2017

Zheng Dong

5

1 reference

31 January 2017

language of work or name

English

0 references

publication date

7 March 2008

1 reference

Journal of Biological Chemistry

31 January 2017

published in

1 reference

31 January 2017

volume

283

1 reference

31 January 2017

issue

10

1 reference

31 January 2017

page(s)

6572–6583

1 reference

Cisplatin: mode of cytotoxic action and molecular basis of resistance

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Cellular processing of platinum anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Cell cycle regulation: repair and regeneration in acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Oxidant mechanisms in toxic acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

A death-promoting role for extracellular signal-regulated kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Multiple States of Stalled T7 RNA Polymerase at DNA Lesions Generated by Platinum Anticancer Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

DNA damage-induced cell death by apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Cell cycle checkpoint signaling through the ATM and ATR kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

DNA damage-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Immortalization and characterization of proximal tubule cells derived from kidneys of spontaneously hypertensive and normotensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

The Chk2 tumor suppressor is not required for p53 responses in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

ATM-dependent CHK2 activation induced by anticancer agent, irofulven

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Differential gender differences in ischemic and nephrotoxic acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

The ATR pathway: fine-tuning the fork

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

The involvement of ataxia-telangiectasia mutated protein activation in nucleotide excision repair-facilitated cell survival with cisplatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Cisplatin-DNA adducts inhibit translocation of the Ku subunits of DNA-PK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

The DNA damage response: ten years after

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

21 January 2018

The Chk2 protein kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

ATR, PML, and CHK2 play a role in arsenic trioxide-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

Loss of ataxia telangiectasia mutated- and Rad3-related function potentiates the effects of chemotherapeutic drugs on cancer cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200

p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707568200